Business
Bionano Announces Extensive Lineup of Content at European Conferences Featuring OGM Utility Across a Broad Range of Research Applications
SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the company’s robust presence at key European cytogenetic
About this update from Bionano Genomics, Inc.
[{"type":"text","content":"SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the company’s robust presence at key European cytogenetic conferences, including the European Hematology Association (EHA) 2023 Congress, the European Human Genetics (ESHG) 2023 Conference and the European Association for Cancer Research (EACR) 2023 Congress. Optical genome mapping (OGM) will be featured in scientific posters and presentations covering a wide range of research applications across key areas including constitutional genetic disorders, rare undiagnosed genetic disease (RUGD), solid tumor analysis and hematological malignancies. Conference information Research application areas Notable posters and presentationsEHAJune 8-11, 2023Frankfurt, Germany 8 scientific posters, including online abstracts, covering hematological malignancy research Scientific posters from Dr. Jose Garcia Martinez (Hospital Infantil Universitario Niño Jesús) and Dr. Jonathan Lühmann (MH Hannover) will cover OGM’s use in pediatric acute lymphoblastic leukemia research.ESHGJune 10-13, 2023Glasgow, Scotland 25 scientific posters and presentations covering research on rare undiagnosed genetic disease and genetic disorders, hematological malignancies and cell line quality control “Rare Diseases and Beyond: Optical Genome Mapping Applications in Cytogenomics and Gene Editing,” sponsored session featuring: Dr. Alka Chaubey (Bionano) covering innovations in the OGM workflowA special announcement of the grand prize recipient of the Bionano Innovator Research GrantPresentations from Dr. Alexander Hoischen (Radboud UMC), Dr. Martine Doco-Fenzy (CHU de Nantes), Dr. Katrina Rack (UZ Leuven), Dr. Rachel Steeg (European Bank for induced Pluripotent Stem Cells) EACRJune 12-15, 2023Torino, Italy Poster information available soon at https://bionano.com/eacr2023/#poster_session “Cancer Cytogenomics and Beyond: Diverse OGM Applications Including Gene Editing,” an overview of OGM’s utility in oncology and cell therapy applications, featuring Dr. Juan Díaz Martín from Institute of Biomedicine of Sevilla (IBiS) and Dr. Marc-Henri Stern from Institut Curie “We are proud to see the broad range of posters and presentations on OGM at three European genetics conferences this year,” commented Erik Holmlin, president and chief executive officer of Bionano. “Researchers and sc...